Back to top

The Path Forward: Advances in Testing and Immunotherapy

18Mar2021
Hosting Organization: 
Glenmede
When: 
Thursday, March 18, 2021
12:00pm - 1:00pm EDT
Add to Calendar

Join Glenmede for a discussion with Marion Pepper, Ph.D., Associate Professor in the Department of Immunology at the University of Washington School of Medicine. Dr. Pepper and Glenmede's CEO, Gordon Fowler, will discuss topical questions surrounding the COVID-19 vaccine rollout, the evolution of the virus and how we move “back to normal,” including:

  • Can one spread the disease even after being vaccinated?
  • Will the vaccine be effective against the new variants?
  • How does the immune system target the virus?

Speakers

Marion Pepper image

 

Marion Pepper, Ph.D.
Associate Professor of Immunology
University of Washington Medical School

Full Bio
 

Dr. Pepper is an Associate Professor in the Department of Immunology at the University of Washington School of Medicine. Her research focuses on how protection from disease, known as immunity, develops. Specifically, her lab strives to understand how specialized immune cells, called T cells and B cells, respond to various types of infection or allergic inflammation in an effort to make better vaccines and therapeutics. Learn more about the Pepper Lab.

Dr. Pepper’s work has been cited over 4,000 times and she is on the editorial board of several top tier journals, including Cell Reports and Immunity. She has served as a scientific consultant for multiple for profit companies focused on immunotherapeutics and is a member of the scientific advisory board of Neoleukin Therapeutics.

She has presented her work at over 70 national and international universities and conferences. In 2017, she was named a recipient of the prestigious Buroughs Wellcome Fund Investigators in the Pathogenesis of Infectious Disease Award.

 

Gordon Fowler image

 

Gordon Fowler
President & CEO
Glenmede

Full Bio


Gordon B. Fowler, Jr. is President and Chief Executive Officer of Glenmede and a Director of The Glenmede Trust Company, N.A. Over the course of his 30+ year career, he has been responsible for the development of numerous equity and asset allocation strategies, and has authored and co-authored several pioneering articles on private client and institutional investing.

 

How to Register/RSVP: 

Register here.

Inquiries about the event? Please contact Kate Monahan at GlenmedeEvents@glenmede.com.